Chase C. Leavitt's Insider Trades & SAST Disclosures
Chase C. Leavitt's most recent trade in Oncternal Therapeutics Inc was a trade of 14,200 Stock Option done . Disclosure was reported to the exchange on Feb. 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chase C. Leavitt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Leavitt C. Chase | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,200 | 14,200 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 03 Jan 2024 | 11,838 | 84,758 (0%) | 0% | 0.5 | 5,873 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 03 Jul 2023 | 10,305 | 96,596 (0%) | 0% | 0.4 | 3,710 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 12 Apr 2023 | 15,000 | 96,901 (0%) | 0% | 0.3 | 4,350 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Purchase of securities on an exchange or from another person at price $ 0.29 per share. | 12 Apr 2023 | 10,000 | 106,901 (0%) | 0% | 0.3 | 2,900 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 210,000 | 210,000 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 03 Jan 2023 | 6,091 | 81,901 (0%) | 0% | 1.0 | 6,213 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 43,125 | 87,992 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 28,750 | 28,750 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 27 Jan 2022 | 8,500 | 39,867 (0%) | 0% | 1.8 | 15,130 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 27 Jan 2022 | 5,000 | 44,867 (0%) | 0% | 1.6 | 8,150 | Common Stock |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 55,519 | 55,519 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Chase C. Leavitt | General Counsel/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 29,867 | 31,367 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges